In an important public health initiative, the Brazilian Ministry of Health has commenced the distribution of the first pediatric formulation of tafenoquine, aiming to combat malaria among children in the Amazon. This new 50 mg dosage is a significant leap forward as Brazil becomes the first country to offer this specific version for children weighing between 10 kg and 35 kg, addressing a critical need since approximately 50% of malaria cases in Brazil occur in children.

The rollout began on Monday, with a focus on gradually distributing the medication, prioritizing regions within the Legal Amazon where malaria is more prevalent. Previously, tafenoquine was only available in a 150 mg dosage meant for adults over the age of 16. The Ministry has allocated a total of 126,120 pediatric tablets for this initial distribution phase, with an investment of R$ 970,000, reflecting the government’s commitment to tackling this public health challenge effectively.

Of particular significance is the focus on Indigenous Special Health Districts (DSEIs), which account for roughly half of malaria cases among children and adolescents under 15 years old. Initial shipments will include 64,800 tablets destined for these districts, ensuring that the most affected populations, such as those in Yanomami, Alto Rio Negro, Rio Tapajós, and Manaus, receive timely access to this vital treatment in the ongoing fight against malaria in the region.